|
10(9M/1F) |
|
21(11M/10F) |
Age(y, mean±std) |
39±13 |
|
46±15 |
Patients with bilateral lesion, n (%) |
5(50%) |
|
10(45%) |
Lund-Mackay score
(mean±std)
|
13±4
|
|
9±4
|
Eosinophils in PB
(109/L, mean±std)
|
0.37±0.25
|
|
0.10±0.08
|
Histological pattern |
|
|
|
edematous |
3(30%) |
|
1(5%) |
fibrotic |
0(0%) |
|
7(33%) |
hyperplasia |
0 |
|
8(38%) |
atypical |
0 |
|
0 |
edematous+fibrotic |
4(40%) |
|
3(14%) |
edematous+hyperplasia |
3(30%) |
|
2(10%) |
CRSwNP, n (%) |
9(100%) |
|
17(81%) |
Comorbidity* |
|
|
|
atopy |
3/7(43%) |
|
5/17(29%) |
asthma |
1/7(14%) |
|
0/17(0) |
aspirin intolerance |
1/7(14%) |
|
1/17(6%) |